These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4806282)

  • 1. [Data on toxicity and individual therapy results on anti-neoplastic antibiotics in the dog].
    Stein E
    Tierarztl Prax; 1973; 1(4):445-56. PubMed ID: 4806282
    [No Abstract]   [Full Text] [Related]  

  • 2. [Data on toxicity and various therapeutic results of antineoplastic antibiotics in the dog].
    Stein E
    Tierarztl Prax; 1973; 1(1):445-56. PubMed ID: 4142522
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possibilities and limits of neoplasm drug therapy].
    Senn HJ
    Schweiz Rundsch Med Prax; 1972 Jul; 61(27):877-83. PubMed ID: 4680951
    [No Abstract]   [Full Text] [Related]  

  • 4. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
    Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity associated with epirubicin treatments in a large case series of dogs.
    Marrington AM; Killick DR; Grant IA; Blackwood L
    Vet Comp Oncol; 2012 Jun; 10(2):113-23. PubMed ID: 22236353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porfiromycin (NSC-56410)--clinical brochure.
    Carter SK
    Cancer Chemother Rep 3; 1968 Dec; 1(1):81-97. PubMed ID: 4989816
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of methoximorpholino-doxorubicin (FCE 23762) in dogs with spontaneous malignancies.
    Sheafor SE; Couto CG; Ward H; Essinger C; Nicol SJ
    J Vet Intern Med; 2000; 14(1):86-9. PubMed ID: 10668822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azotomycin (NSC-56654)--clinical brochure.
    Carter SK
    Cancer Chemother Rep 3; 1968 Dec; 1(1):207-17. PubMed ID: 4917775
    [No Abstract]   [Full Text] [Related]  

  • 10. Preclinical selection of new anthracyclines.
    Casazza AM
    Cancer Treat Rep; 1986 Jan; 70(1):43-9. PubMed ID: 3510737
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxicity of formycin B to hamster and dog.
    Berman JD; Hanson WL; Chapman WL; Waits VB; Cox RH
    J Parasitol; 1987 Dec; 73(6):1267-8. PubMed ID: 3437362
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of a 1-hour IV infusion of doxorubicin on the development of cardiotoxicity in dogs as evaluated by electrocardiography and echocardiography.
    Gillings S; Johnson J; Fulmer A; Hauck M
    Vet Ther; 2009; 10(1-2):46-58. PubMed ID: 19742448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract]   [Full Text] [Related]  

  • 14. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07).
    Heading KL; Brockley LK; Bennett PF
    Aust Vet J; 2011 Apr; 89(4):109-16. PubMed ID: 21418164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The antitumoral and toxic effect of individual aurantins (actinomycins)].
    Zubova OV
    Dokl Akad Nauk SSSR; 1965 Jun; 162(4):934-6. PubMed ID: 4163110
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicology of anticancer drugs.
    Guarino AM
    Natl Cancer Inst Monogr; 1977 Mar; (45):49-55. PubMed ID: 412105
    [No Abstract]   [Full Text] [Related]  

  • 17. [Histological study of dog organs under the effect of sibiromycin].
    Muraveĭskaia VS
    Antibiotiki; 1971 Sep; 16(9):810-6. PubMed ID: 5139453
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of clinical studies on aclacinomycin A--phase I and preliminary phase II evaluation of ACM.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1978 Dec; 25(3-4):37-49. PubMed ID: 572582
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical toxicity of anticancer drugs and its prediction.
    Creaven PJ; Mihich E
    Semin Oncol; 1977 Jun; 4(2):147-63. PubMed ID: 406677
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antineoplastic and toxic effects of blastolysin in the treatment of spontaneous mammary cancer in dogs].
    Zontov SV; Rampan IuI; Syrkin AB; Iliukhin AV; Kliuchanskaia NV
    Eksp Onkol; 1984; 6(2):58-60. PubMed ID: 6510337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.